Assessment of nicotine dependence in subjects with vascular dementia


  • Mina Chandra Department of Psychiatry, Post Graduate Institute of Medical Education and Research and Dr. Ram Manohar Lohia Hospital, New Delhi
  • Kuljeet Singh Anand Department of Neurology, Post Graduate Institute of Medical Education and Research and Dr. Ram Manohar Lohia Hospital, New Delhi


Nicotine, Tobacco, Vascular dementia, Severity


Background: Nicotine dependence is an important public health issue. Nicotine dependence is a risk factor for vascular diseases like myocardial infarction and vascular dementia. The rate of nicotine dependence in Indian subjects with vascular dementia is not known. Hence we decided to assess nicotine dependence in subjects with vascular dementia.

Methods: Nicotine dependence in subjects with vascular dementia was assessed among subjects presenting to memory clinic of a tertiary care hospital over a period of 16 months. Data regarding sociodemographic profile and severity of nicotine dependence as per Fagerstrom nicotine dependence scale for smoking and smokeless tobacco was analysed using SPSS version 17.

Results: Our study shows that in 159 subjects with vascular dementia continuing nicotine dependence was seen in nearly 12% of the subjects. Though the rates are less than the population prevalence for India, it is still relevant as nicotine is not just a risk factor for development of vascular dementia but severe nicotine dependence and longer duration of nicotine use were found to be poor prognostic factors associated with severe dementia. Further as all subjects continued to be nicotine dependent despite having been advised to quit tobacco, suggesting the need for a more comprehensive tobacco cessation intervention be offered to subjects with vascular dementia to improve outcomes.

Conclusion: In subjects with vascular dementia continuing nicotine dependence is an important risk factor which must be addressed.  



Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JCM, Van Broeckhoven C, et al. Smoking and risk of dementia and AD in a population-based cohort study: the Rotterdam study. Lancet. 1998;351:1840-3.

Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JRM, et al. Effect of smoking on global cognitive function in non-demented elderly. Neurology. 2004;62:920-4.

Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, et al. Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study. Arch Gen Psychiatry. 2012;69(6):627-35.

Ferri CP, West R, Moriyama TS, Acosta D, Guerra M, Huang Y, et al. Tobacco use and dementia: evidence from the 1066 dementia population-based surveys in Latin America, China and India. Int J Geriatr Psychiatry. 2011;26:1177-85.

Román, GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc. 2003;51:S296-304.

Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812-26.

Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer’s disease and vascular dementia. Ann N Y Acad Sci. 2000;903:411-23.

Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4(2):363-81.

Peters R, Poulter R, Warner J, Beckett N, Burch N, Bulpitt C. Smoking, dementia, and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8:36.

Tyas SL, White LR, Petrovitch H, Webster Ross G, Foley DJ, Heimovitz HK, et al. Mid-life smoking and late-life dementia: the Honolul-Asia Aging study. Neurobiol Aging. 2003;24(4):589-96.

Bazzano LA, He J, Muntner P, Suma Vupputuri S, Paul K, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Int Med. 2003;138:891-7.

Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large- and small-artery disease and not other etiologic subtypes of ischemic stroke. Stroke. 2000;31:1069-75.

Sachdev P, Valenzuela MJ, Brodaty H, Wang XL, Looi J, Lorentz L, et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cognit Disord. 2003;15(3):155-62.

Broadstock M. Systematic review of the health effects of modified smokeless tobacco products. N Z Health Technol Assess Rep. 2007;10(1):1-131.

McKenzie J, Bhatti L, Tursan d’Espaignet E. Tobacco and dementia. In: WHO, eds. Tobacco Knowledge Summaries. Geneva: WHO; 2014: 1-4.

Swan GE, Lessov-Schlager CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17(3):259-73.

Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer’s disease brain: new insights from redox proteomics. Eur J Pharmacol. 2006;545:39-50.

Anstey KJ, von Sanden C, Salim A, O’ Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007;166(4):367-78.

Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250-60.

Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(Suppl 1):173-6.

Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119-27.

Ebbert JO, Patten CA, Schroeder DR. The Fagerström test for nicotine dependence-smokeless tobacco (FTND-ST). Addict Behav. 2006;31(9):1716-21.

Korczyn AD. Is dementia preventable? Dialog Clin Neurosci. 2009;11(2):213-6.

Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med. 2011;171(4):333-9.

International Institute for Population Sciences, Ministry of Health and Family Welfare, Government of India. Global adult tobacco survey India (GATS India), 2009-10. New Delhi: Ministry of Health and Family Welfare; Mumbai: International Institute for Population Sciences; 2010. Available at: Accessed 19 January 2015.

Takahashi PY, Caldwell CR, Targonski PV. Effect of alcohol and tobacco use on vascular dementia: a matched case control study. Vasc Health Risk Manag. 2011;7:685-91.




How to Cite

Chandra, M., & Anand, K. S. (2017). Assessment of nicotine dependence in subjects with vascular dementia. International Journal of Research in Medical Sciences, 3(3), 711–714. Retrieved from



Original Research Articles